Psychiatric disease and drug abuse

Current Opinion in Pediatrics

Volumn 24, Issue 2, 2012, Pages

  Santucci, Karen ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

drug abuse; dual diagnosis; pediatric psychiatric illness; substance use disorder

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; ANTIDEPRESSANT AGENT; BUPRENORPHINE; CLOZAPINE; COCAINE; CODEINE; DIAMORPHINE; DIPHENOXYLATE; DOPAMINE; FENTANYL; GLUTAMINE; LYSERGIDE; MODAFINIL; MORPHINE; NEUROLEPTIC AGENT; PARACETAMOL; PHENOBARBITAL; PRESCRIPTION DRUG; PROPYLHEXEDRINE; STREET DRUG;

ACT; ALCOHOL ABUSE; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; BIPOLAR DISORDER; CANNABIS SMOKING; CHILDHOOD DISEASE; CIGARETTE SMOKING; COMORBIDITY; DIAGNOSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG OVERDOSE; DUAL DIAGNOSIS; EMOTIONAL DISORDER; GENETIC RISK; HEALTH EDUCATION; HIGH SCHOOL STUDENT; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; MOOD DISORDER; MORTALITY; MOTIVATION; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT COMPLIANCE; PEDIATRICIAN; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; SCHIZOPHRENIA; SELF MEDICATION; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

ADOLESCENT; CHILD; DIAGNOSIS, DUAL (PSYCHIATRY); HUMANS; MENTAL DISORDERS; SUBSTANCE-RELATED DISORDERS;

EID: 84859108699     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0b013e3283504fbf     Document Type: Review

References (40)

1. Kohn R, Saxena S, Levav I, Saraceno B. The treatment gap in mental healthcare. Bull World Health Organ 2004; 82:858.
2. New Freedom Commission on Mental Health. Achieving the Promise: Transforming Mental Healthcare in America. DHHS. Final Report. Publication no. SMA-03-3832. Rockville, MD; 2003.
3. Bohnert AS, IIgen MA, Ignacio RV, et al. Risk of death from accidental overdose associated with psychiatric and substance use disorders. Am J Psychiatry 2011. [Epub ahead of print] This study suggests the importance of risk assessment and overdose prevention for vulnerable clinical subpopulations.
4. Johnston LD, O'Malley PM, Bachman JG, et al. Monitoring the future: national results in adolescent drug use: overview of key findings. Bethesda, MD: National Institute on Drug Abuse; 2005.
5. Havens JR, Young AM, Havens CE. Nonmedical prescription drug use in a nationally representative sample of adolescents: evidence of greater use among rural adolescents. Arch Pediatr Adolesc Med 2011; 165:250-255.
6. Diaz R, Goti J, Garcia M, et al. Patterns of substance use in adolescents attending a mental health department. Eur Child Adolesc Psychiatry 2011; 20:279-289. This study reports patterns of substance use in adolescents initiating mental health treatment and analyzed factors associated with a high-risk pattern of substance use differentially by sex.
7. Roberts RE, Roberts CR, Xing Y. Comorbidity of substance use disorders and other psychiatric disorders among adolescents: evidence from an epidemiologic survey. Drug Alcohol Depend 2007; 88:4-13.
8. Shrier LA, Harris SK, Kurland M, et al. Substance use problems and associated psychiatric symptoms among adolescents in primary care. Pediatrics 2003; 111:699-705.
9. Becker DF, Grilo CM. Prediction of drug and alcohol use in hospitalized adolescents: comparisons by gender and substance type. Behav Res Ther 2006; 44:1431-1440. (Pubitemid 44414761)
10. Swadi H, Bobier C. Substance use disorder comorbidity among in patient youths with psychiatric disorder. Aust N Z J Psychiatry 2003; 37:294-298. (Pubitemid 36833759)
11. Niethammer O, Frank R. Prevalence of use, abuse and dependence on legal and illegal psychotropic substances in an adolescent in patient psychiatric population. Eur Child Adolesc Psychiatry 2007; 16:254-259. (Pubitemid 46919533)
12. Kramer TL, Robbins JM, Phillips SD, et al. Detection and outcomes of substance use disorders in adolescents seeking mental health treatment. J Am Acad Child Adolesc Psychiatry 2003; 42:1318-1326. (Pubitemid 39585992)
13. Chambers RA, Bickel WK, Potenza MN. A call-free systems theory of motivation and addiction. Neurosci Biobehav Rev 2007; 31:1017.
14. Krystal JH, D'Souza DC, Gallinat J, et al. The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia. Neurotox Res 2006; 10:235.
15. Kessler RC. The epidemiology of dual diagnosis. Biol Psychiatry 2004; 56:730.
16. Semple DM, McIntosh AM, Lawrie SM. Cannabis as arisk factor for psychosis: systematic review. J Psychopharmacol 2005; 19:187.
17. Lyne JP, O'Donoghue B, Clancy M, et al. Comorbid psychiatric diagnoses among individuals presenting to an addiction treatment program for alcohol dependence. Substance Use Misuse 2011; 46:351-358.
18. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264:2511.
19. Graham AW, Schultz TK, Mayo-Smith MF, et al., editors. Principles of addiction medicine. 3rd ed. Chevy Chase, MD: American Society of Addiction Medicine Inc.; 2003.
20. Hernandez SH, Nelson LS. Prescription drug abuse: insight into the epidemic. Clin Pharmacol Ther 2010; 88:307-317. This study reviewed the epidemiology of nonmedical prescription drug use and detailed specific morbidity and mortality.
21. Rogers PD, Copley L. The nonmedical use of prescription drugs by adolescents. Adolesc Med State Art Rev 2009; 20:1-8; vii.
22. Institute of Medicine (US) Committee on Crossing the Quality Chasm: Adaptation to Mental Health and Addictive Disorders. Washington, DC: National Academies Press (US); 2006. p. 210.
23. Kelly TM, Daley DC, Doualhy AB. Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav 2012; 37:11-24. This article explains the need for creative combinations of psychotherapies, behavioral and pharmaceutical interventions needed most to appropriately treat patients with a dual diagnosis.
24. Bohnert AS, I Igen MA, Ignacio RV, et al. Risk of death from accidental overdose associated with psychiatric and substance use disorders. Am J Psychiatry 2011. [Epub ahead of print] [03]
25. Buttner A. Review: The neuropathology of drug abuse [Review]. Neuropathol Appl Neurobiol 2011; 37:118-134.
26. Calia R, Lai C, Aceto P, Luciani M, et al. Psychological Risk Factors for Graft Rejection Among Liver Transplant Recipients. Transplant Proc 2011; 43:1123-1127.
27. Caputo F, Francini S, Brambilla R,Vigna-Taglianti F, et al. Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity. Eur Neuropsychopharmacol 2011; 21:450-456.
28. Diaz R, Goti J, Garcia M, et al. Patterns of substance use in adolescents attending a mental health department. Eur Child Adolesc Psychiatry 2011; 20:279-289. [06]
29. Hernandez SH, Nelson LS. Prescription drug abuse: insight into the epidemic. Clin Pharmacol Ther 2010; 88:307-317. [20]
30. Ho BC, Andreasen NC, Ziebell S, Pierson R, et al. Long-term Antipsychotic Treatment and Brain Volumes A Longitudinal Study of First-Episode Schizophrenia. Arch Gen Psychiatry 2011; 68:128-137.
31. Huang MW, Chou FHC, Lo PY, Cheng KS. A comparative study on long-term evoked auditory and visual potential responses between Schizophrenic patients and normal subjects - art. no. 74. BMC Psychiatry 2011:74.
32. Jonas S, Bebbington P, McManus S, Meltzer H, et al. Sexual abuse and psychiatric disorder in England: results from the 2007 Adult Psychiatric Morbidity Survey. Psychol Med 2011; 41:709-719.
33. Kang JH, Lin HC. Comorbidity profile of poliomyelitis survivors in a Chinese population: a population-based study. J Neurol 2011; 258:1026-1033.
34. Katz G, Durst R, Shufman E, Bar-Hamburger R, et al. A Comparative Study of psychiatric In patients in a General Hospital and a Psychiatric Hospital in Israel: Demographics, Psychopathological Aspects and Drug Abuse Patterns. Isr Med Assoc J 2011; 13:329-332, 2011 Jun.
35. Kelly TM, Daley DC, Doualhy AB. Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav 2012; 37:11-24. [23]
36. Mao AR, Babcock T, Brams M. ADHD in Adults: Current Treatment Trends with Consideration of Abuse Potential of Medications. J Psychiatr Pract 2011; 17:241-250.
37. Naude CE, Bouic P, Senekal M, Kidd M, et al. Lymphocyte measures intreatment-naive 13-15-year old adolescents with alcohol use disorders. Alcohol 2011; 45:507-514.
38. Omland LH, Jepsen P, Krarup H, Schonning K, et al. Increased Mortality Among Persons InfectedWith Hepatitis C Virus. Clin Gastroenterol Hepatol 2011; 9:71-78.
39. Satre DD, Sterling SA, Mackin RS, Weisner C. Patterns of alcohol and Drug Use Among Depressed Older Adults Seeking Outpatient Psychiatric Services. Am J Geriatr Psychiatry 2011; 19:695-703.
40. Taurines R, Dudley E, Grassl J, Warnke A, et al. Proteomic research in psychiatry [Review]. J Psychopharmacol 2011; 25:151-196.